Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Although the role of HER2 in prostate cancer remains controversial, HER2 can be overexpressed during prostate cancer progression. In this study, we prospectively isolated circulating tumor cells (CTCs) from 41 men with metastatic castration-resistant prostate cancer (mCRPC). Then, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Maillet, Denis, Allioli, Nathalie, Péron, Julien, Plesa, Adriana, Decaussin-Petrucci, Myriam, Tartas, Sophie, Sajous, Christophe, Ruffion, Alain, Crouzet, Sébastien, Freyer, Gilles, Vlaeminck-Guillem, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656805/
https://www.ncbi.nlm.nih.gov/pubmed/34885125
http://dx.doi.org/10.3390/cancers13236014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656805/
https://www.ncbi.nlm.nih.gov/pubmed/34885125
http://dx.doi.org/10.3390/cancers13236014

Ejemplares similares